Report Detail
Global (United States, European Union and China) Cancer Vaccine Market Research Report 2019-2025
- RnM3578832 |
- 08 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system’s ability to fight against infections and diseases. It is used either as stand-alone therapies or in combination with traditional cancer therapeutics such as chemotherapy and surgery. As cancer is often associated with high mortality rate and are resistant to traditional treatments like chemotherapy and radiation, this has led to the research and development of anti-cancer immunotherapies. The side effects of cancer vaccines may differ from person to person. The most commonly reported are inflation at the site of injection, fever, chills, nausea, blood pressure, and among others.
In 2019, the market size of Cancer Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cancer Vaccine.
This report studies the global market size of Cancer Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cancer Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Dendreon Corporation
NeoStem Oncology
ImmunoGen
Inovio Pharmaceuticals
Novartis
...
Market Segment by Product Type
Preventive vaccines
Therapeutic vaccines
Market Segment by Application
Prostate Cancer
Cervical Cancer
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Cancer Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Cancer Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Cancer Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Cancer Vaccine Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Preventive vaccines
- 1.3.3 Therapeutic vaccines
- 1.4 Market Segment by Application
- 1.4.1 Global Cancer Vaccine Market Share by Application (2019-2025)
- 1.4.2 Prostate Cancer
- 1.4.3 Cervical Cancer
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Cancer Vaccine Market Size
- 2.1.1 Global Cancer Vaccine Revenue 2014-2025
- 2.1.2 Global Cancer Vaccine Sales 2014-2025
- 2.2 Cancer Vaccine Growth Rate by Regions
- 2.2.1 Global Cancer Vaccine Sales by Regions 2014-2019
- 2.2.2 Global Cancer Vaccine Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Cancer Vaccine Sales by Manufacturers
- 3.1.1 Cancer Vaccine Sales by Manufacturers 2014-2019
- 3.1.2 Cancer Vaccine Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Cancer Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Cancer Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Cancer Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.3 Cancer Vaccine Price by Manufacturers
- 3.4 Key Manufacturers Cancer Vaccine Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Cancer Vaccine Market
- 3.6 Key Manufacturers Cancer Vaccine Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Preventive vaccines Sales and Revenue (2014-2019)
- 4.1.2 Therapeutic vaccines Sales and Revenue (2014-2019)
- 4.2 Global Cancer Vaccine Sales Market Share by Type
- 4.3 Global Cancer Vaccine Revenue Market Share by Type
- 4.4 Cancer Vaccine Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Cancer Vaccine Sales by Application
6 United States
- 6.1 United States Cancer Vaccine Breakdown Data by Company
- 6.2 United States Cancer Vaccine Breakdown Data by Type
- 6.3 United States Cancer Vaccine Breakdown Data by Application
7 European Union
- 7.1 European Union Cancer Vaccine Breakdown Data by Company
- 7.2 European Union Cancer Vaccine Breakdown Data by Type
- 7.3 European Union Cancer Vaccine Breakdown Data by Application
8 China
- 8.1 China Cancer Vaccine Breakdown Data by Company
- 8.2 China Cancer Vaccine Breakdown Data by Type
- 8.3 China Cancer Vaccine Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Cancer Vaccine Breakdown Data by Company
- 9.2 Rest of World Cancer Vaccine Breakdown Data by Type
- 9.3 Rest of World Cancer Vaccine Breakdown Data by Application
- 9.4 Rest of World Cancer Vaccine Breakdown Data by Countries
- 9.4.1 Rest of World Cancer Vaccine Sales by Countries
- 9.4.2 Rest of World Cancer Vaccine Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Dendreon Corporation
- 10.1.1 Dendreon Corporation Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Cancer Vaccine
- 10.1.4 Cancer Vaccine Product Introduction
- 10.1.5 Dendreon Corporation Recent Development
- 10.2 NeoStem Oncology
- 10.2.1 NeoStem Oncology Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Cancer Vaccine
- 10.2.4 Cancer Vaccine Product Introduction
- 10.2.5 NeoStem Oncology Recent Development
- 10.3 ImmunoGen
- 10.3.1 ImmunoGen Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Cancer Vaccine
- 10.3.4 Cancer Vaccine Product Introduction
- 10.3.5 ImmunoGen Recent Development
- 10.4 Inovio Pharmaceuticals
- 10.4.1 Inovio Pharmaceuticals Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Cancer Vaccine
- 10.4.4 Cancer Vaccine Product Introduction
- 10.4.5 Inovio Pharmaceuticals Recent Development
- 10.5 Novartis
- 10.5.1 Novartis Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Cancer Vaccine
- 10.5.4 Cancer Vaccine Product Introduction
- 10.5.5 Novartis Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Cancer Vaccine Sales Channels
- 11.2.2 Cancer Vaccine Distributors
- 11.3 Cancer Vaccine Customers
12 Market Forecast
- 12.1 Global Cancer Vaccine Sales and Revenue Forecast 2019-2025
- 12.2 Global Cancer Vaccine Sales Forecast by Type
- 12.3 Global Cancer Vaccine Sales Forecast by Application
- 12.4 Cancer Vaccine Forecast by Regions
- 12.4.1 Global Cancer Vaccine Sales Forecast by Regions 2019-2025
- 12.4.2 Global Cancer Vaccine Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Cancer Vaccine. Industry analysis & Market Report on Cancer Vaccine is a syndicated market report, published as Global (United States, European Union and China) Cancer Vaccine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Cancer Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
